日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Camrelizumab plus CAPOX with camrelizumab based maintenance versus CAPOX alone as initial treatment for gastric or gastro-oesophageal junction adenocarcinoma: randomised phase 3 trial

卡瑞利珠单抗联合 CAPOX 方案(以卡瑞利珠单抗为基础的维持治疗)与单用 CAPOX 方案作为胃癌或胃食管交界处腺癌一线治疗的疗效比较:一项随机 3 期试验

Peng, Zhi; Zhang, Yanqiao; Xu, Huiting; Yang, Yan; Yang, Mudan; Zhang, Mingjun; Cheng, Ying; Chen, Xiaobing; Pan, Yueyin; Wang, Feng; Li, Qingshan; Xu, Nong; Liu, Likun; Gu, Kangsheng; Xiao, Juxiang; Zhang, Ruixing; Zhao, Qun; Chen, Jian; Lin, Lizhu; Chen, Yigui; Deng, Yanhong; Cai, Shirong; Bai, Bin; Wang, Yiru; Shen, Lin

Platinum-based functional nanomaterials: mechanisms and therapeutic strategies in cancer radiotherapy sensitization

铂基功能纳米材料:癌症放射治疗增敏的机制和治疗策略

Cheng, Yuanchao; Mou, Yakui; Wang, Hanrui; Shen, Hui; Hu, Yue; Song, Xiaoyu; Zhang, Mingjun; Wang, Yao; Liu, Wanchen; Yang, Ting; Ren, Chao; Yan, Miao; Song, Xicheng

Deciphering Neural Mechanisms Underlying Marmoset Dynamic Natural Behaviors Using a Miniaturized Wireless Large-Scale Coverage Neural Recorder

利用小型化无线大规模覆盖神经记录仪破译狨猴动态自然行为背后的神经机制

Liu, Hongru; Cao, Xinyuan; Li, Jiyong; Zheng, Lingyi; Li, Jingwei; Li, Qianbing; Xie, Min; Li, Huimin; Wang, Xiaolong; Wu, Yuyu; Zhang, Xiangyu; Wang, Yizheng; Gao, Xize; Sheng, Tiancheng; Du, Nianzhen; Xu, Chengao; Zhou, Kai; Xu, Jing; Yan, Changxiang; Liu, Lianqing; Gao, Lixia; Li, Xinjian; Zhang, Mingjun

Wafer-Scale Bandgap-Tunable MoS(2)/PbS Phototransistors Enabled by Solution Processing

溶液法制备的晶圆级带隙可调 MoS₂/PbS 光电晶体管

Tang, Ziheng; Cui, Chengqian; Jing, Xiaoli; You, Rui; Zhang, Mingjun; Xu, Jing

Pleural cavity macrophages promote lung tumor establishment through tissue invasion

胸膜腔巨噬细胞通过组织侵袭促进肺肿瘤的发生发展。

Zhang, Zhenqian; Jin, Hengwei; Liu, Zhicong; Shi, Mengyang; Zhang, Mingjun; Pu, Wenjuan; Li, Jie; Li, Xuekun; Ma, Daqing; Shu, Qiang; Zhou, Bin

Overcoming tumor microenvironment barriers: transformable and bioinspired nanomedicine strategies for deep tumor penetration

克服肿瘤微环境屏障:用于深层肿瘤渗透的可转化和仿生纳米药物策略

Sheng, Jiabao; Yuan, Weisi; Zhang, Mingjun; Chen, Ze; Qi, Yanfei; Zhao, Yinan; Zhang, Shubiao

Lineage tracing reveals the origins and dynamics of macrophages in lung injury and repair.

谱系追踪揭示了巨噬细胞在肺损伤和修复中的起源和动态。

Jin Hengwei, Mou Jialing, Zhu Huan, Liu Kuo, Zhang Mingjun, Zhang Zhenqian, Pflanz Stefan, Kasmi Karim Ei, Liu Zhaoyuan, Ginhoux Florent, Lui Kathy O, Zhou Bin

Advancing precision tumor therapy: Progress in targeted delivery of peptide-based nanomaterials from microenvironment to organelles

推进精准肿瘤治疗:基于肽的纳米材料从微环境到细胞器的靶向递送进展

Tian, Kexin; Sheng, Jiabao; Chen, Jiao; Zhang, Mingjun; Song, Jiarui; Wu, Manqing; Zhao, Yinan; Zhang, Shubiao

In vivo CRISPR/Cas9 Screening Reveals that UBE2L3 Modulates Autophagic Flux through TSC2 Ubiquitination and Potentiates PD-1 Blockade in Triple-Negative Breast Cancer.

体内 CRISPR/Cas9 筛选揭示 UBE2L3 通过 TSC2 泛素化调节自噬通量,并增强三阴性乳腺癌中 PD-1 阻断作用。

Xu Jian, Cheng Ling, Ma Sien, Gan Chen, Chai Jiaying, Zheng Xinyi, Hu Longyu, Ling Meiwen, Zhang Mingjun, Zhao Bao, Cheng Huaidong

Safety and preliminary efficacy results of IBI389, an anti-Claudin18.2×CD3 bispecific antibody, in patients with solid tumors and gastric or gastro-esophageal tumors: a phase 1 dose escalation and expansion study

IBI389(一种抗Claudin18.2×CD3双特异性抗体)在实体瘤和胃或胃食管肿瘤患者中的安全性和初步疗效结果:一项1期剂量递增和扩展研究

Li, Xiaoyu; Dai, Ruihong; Xu, Qi; Guo, Zengqing; Hu, Changlu; Sun, Yuping; Niu, Zuoxing; Hao, Jihui; Zhang, Mingjun; Dai, Guanghai; Hua, Dong; Pan, Yueyin; Wang, Xin; Wei, Shuqing; Chen, Xiaobing; Wu, Qian; Zhang, Yulong; Zhou, Hui; Ying, Jieer; Zheng, Li; Bi, Feng